PofoliaShared via Pofolia

Science· 2020Q1

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett, Jory A. Goldsmith et al.

Short summary

Researchers determined the 3.5-angstrom cryo-EM structure of the 2019-nCoV spike protein in its prefusion state, revealing a predominant conformation with one receptor-binding domain accessible for interaction.

AI-generated from the title and abstract; the full text is not read.

Key points

  • 3.5-angstrom resolution cryo-EM structure of 2019-nCoV spike protein obtained.
  • Predominant prefusion conformation shows one receptor-binding domain in an accessible 'up' state.
  • 2019-nCoV spike binds ACE2 with higher affinity than SARS-CoV spike.
  • SARS-CoV RBD-specific antibodies show limited binding to 2019-nCoV spike protein.

AI-generated from the title and abstract; the full text is not read.

Abstract

The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.

The authors' abstract, as published at the source. Science, 2020 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Infectious Diseases

Infectious DiseasesMedicine